4//SEC Filing
GUGGENHIME ANDREW 4
Accession 0001649094-25-000049
CIK 0001649094other
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 8:05 AM ET
Size
6.9 KB
Accession
0001649094-25-000049
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
GUGGENHIME ANDREW
PRESIDENT AND CFO
Transactions
- Exercise/Conversion
Common Stock
2025-04-07$20.93/sh+4,777$99,983→ 131,950 total - Exercise/Conversion
Stock Option (right to buy)
2025-04-07−4,777→ 121,115 totalExercise: $20.93Exp: 2031-03-31→ Common Stock (4,777 underlying)
Footnotes (1)
- [F1]Stock Option is fully vested and exercisable.
Documents
Issuer
Vaxcyte, Inc.
CIK 0001649094
Entity typeother
Related Parties
1- filerCIK 0001230724
Filing Metadata
- Form type
- 4
- Filed
- Apr 8, 8:00 PM ET
- Accepted
- Apr 9, 8:05 AM ET
- Size
- 6.9 KB